Cornelis (Kees) Melief received an award from the Association for Cancer Immunotherapy CIMT, an organization headquartered in Mainz, Germany.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
